Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma.
- for the CC-92480-MM-001 Study Investigators
- Dana-Farber Cancer Institute
- University of Toronto
- University College London Hospitals NHS Foundation Trust
- Hospital Clínico Universitario de Salamanca
- University of Copenhagen
- Oxford University Hospitals NHS Foundation Trust
- Complutense University
- University of Melbourne
- University of Texas MD Anderson Cancer Center
- Hospital Universitario La Fe
- Emory University
- City of Hope National Med Center
- The Institute of Cancer Research
- Royal Marsden NHS Foundation Trust
- Generalitat de Catalunya
- Sarah Cannon Research Institute
- University of Navarra
- Hospital San Pedro de Alcántara
- Bristol-Myers Squibb
- University of Calgary
Research output: Contribution to journal › Article › peer-review
68
Link opens in a new tab
Scopus
citations